Patrick Homer | Life Science Director, North EMEA.

Patrick Homer, Life Science Director, North EMEA., SAS

Patrick Homer is a thought leader in the field of transformational analytics across clinical and commercial pharma and has been involved with both the long-term strategy and development of SAS' solutions in these areas.
His analytical expertise resides in predictive, optimization, business intelligence, data management, forecasting, artificial intelligence and the development of analytical platforms. Since joining SAS in 2008, Patrick has overseen the development of a portfolio of advanced analytical capabilities for life sciences. Most recently Patrick lead the development of an analytical platform for global price intelligence, revolutionizing the industry approach to global launch sequencing with next generation optimization algorithms.
Prior to working at SAS, Patrick spent 20 years in the pharmaceutical industry, progressing through sales and management roles and on to executive business development for outsourced sales teams. Patrick graduated with a master’s degree in business administration from University College of Cardiff Business School and a bachelor’s degree in microbiology from University College of Swansea.


Day One World Pharma Pricing & Market Access EU Congress @ 11:25

Start as You Mean to Finish: Why Global Launch Sequence optimization is Critical to Value Throughout the Product Life Cycle

back to speakers